These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35072430)

  • 1. Severe secondary peritonitis: impact of inappropriate initial antimicrobial therapy on prognosis and potential carbapenem-sparing.
    Georges H; Krings A; Devos P; Delannoy PY; Boussekey N; Thellier D; Jean-Michel V; Caulier T; Leroy O
    Minerva Anestesiol; 2022 May; 88(5):361-370. PubMed ID: 35072430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care-an analysis of the OUTCOMEREA database.
    Morvan AC; Hengy B; Garrouste-Orgeas M; Ruckly S; Forel JM; Argaud L; Rimmelé T; Bedos JP; Azoulay E; Dupuis C; Mourvillier B; Schwebel C; Timsit JF;
    Crit Care; 2019 Sep; 23(1):307. PubMed ID: 31492201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of appropriateness of empiric therapy on outcomes in community-onset bacteremia by extended-spectrum-β-lactamase producing Escherichia coli and Klebisella pneumoniae definitively treated with carbapenems.
    Joo EJ; Park DA; Lee NR; Moon SY; Choi JK; Ko JH; Peck KR
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2093-2100. PubMed ID: 28643188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia.
    Kamata K; Suzuki H; Kanemoto K; Tokuda Y; Shiotani S; Hirose Y; Suzuki M; Ishikawa H
    J Infect Chemother; 2015 Aug; 21(8):596-603. PubMed ID: 26070781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a Carbapenem Antimicrobial Stewardship Program on Patient Outcomes.
    Seah VXF; Ong RYL; Lim ASY; Chong CY; Tan NWH; Thoon KC
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28717037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum adequacy of antibiotic regimens for secondary peritonitis: a retrospective analysis in intermediate and intensive care unit patients.
    Steinbach CL; Töpper C; Adam T; Kees MG
    Ann Clin Microbiol Antimicrob; 2015 Nov; 14():48. PubMed ID: 26541549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a multimodal strategy combining a new standard of care and restriction of carbapenems, fluoroquinolones and cephalosporins on antibiotic consumption and resistance of Pseudomonas aeruginosa in a French intensive care unit.
    Abbara S; Pitsch A; Jochmans S; Hodjat K; Cherrier P; Monchi M; Vinsonneau C; Diamantis S
    Int J Antimicrob Agents; 2019 Apr; 53(4):416-422. PubMed ID: 30537533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inappropriate use of carbapenems in an internal medicine ward: Impact of a carbapenem-focused antimicrobial stewardship program.
    Faraone A; Poggi A; Cappugi C; Tofani L; Riccobono E; Giani T; Fortini A
    Eur J Intern Med; 2020 Aug; 78():50-57. PubMed ID: 32303455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basis for selecting optimum antibiotic regimens for secondary peritonitis.
    Maseda E; Gimenez MJ; Gilsanz F; Aguilar L
    Expert Rev Anti Infect Ther; 2016; 14(1):109-24. PubMed ID: 26568097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inappropriate empirical antibiotic therapy does not adversely affect the clinical outcomes of patients with acute pyelonephritis caused by extended-spectrum β-lactamase-producing Enterobacteriales.
    Kim SH; Oh S; Huh K; Cho SY; Kang CI; Chung DR; Peck KR
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):937-944. PubMed ID: 30868326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbapenem use in critically ill patients.
    Patrier J; Timsit JF
    Curr Opin Infect Dis; 2020 Feb; 33(1):86-91. PubMed ID: 31815750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients.
    Ogutlu A; Guclu E; Karabay O; Utku AC; Tuna N; Yahyaoglu M
    Ann Clin Microbiol Antimicrob; 2014 Jan; 13():7. PubMed ID: 24405720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study.
    Zilberberg MD; Kollef MH; Arnold H; Labelle A; Micek ST; Kothari S; Shorr AF
    BMC Infect Dis; 2010 Jun; 10():150. PubMed ID: 20525301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trauma and Antimicrobial Resistance Are Independent Predictors of Inadequate Empirical Antimicrobial Treatment of Ventilator-Associated Pneumonia in Critically Ill Patients.
    Jovanovic B; Djuric O; Hadzibegovic A; Jovanovic S; Stanisavljevic J; Milenkovic M; Rajkovic M; Ratkovic S; Markovic-Denic L
    Surg Infect (Larchmt); 2021 Sep; 22(7):730-737. PubMed ID: 33439780
    [No Abstract]   [Full Text] [Related]  

  • 15. Carbapenems in clinical practice: a guide to their use in serious infection.
    Bradley JS; Garau J; Lode H; Rolston KV; Wilson SE; Quinn JP
    Int J Antimicrob Agents; 1999 Feb; 11(2):93-100. PubMed ID: 10221411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in critically ill patients suffering from secondary peritonitis: a retrospective, observational, survival time analysis.
    Schneider CP; Seyboth C; Vilsmaier M; Küchenhoff H; Hofner B; Jauch KW; Hartl WH
    World J Surg; 2009 Jan; 33(1):34-43. PubMed ID: 18979129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the relevance of carbapenem prescriptions by an antibiotic stewardship team.
    Perron J; Baldolli A; Isnard C; de La Blanchardière A; Saint-Lorant G
    Med Mal Infect; 2020 Jun; 50(4):346-351. PubMed ID: 31257064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The quick loss of carbapenem susceptibility in Pseudomonas aeruginosa at intensive care units.
    Zou Y; Lian J; Di Y; You H; Yao H; Liu J; Dong Y
    Int J Clin Pharm; 2018 Feb; 40(1):175-182. PubMed ID: 29134489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems.
    Kollef MH
    Respir Care; 2004 Dec; 49(12):1530-41. PubMed ID: 15571647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for excessively prolonged meropenem use in the intensive care setting: a case-contol study.
    Katchanov J; Kreuels B; Maurer FP; Wöstmann K; Jochum J; König C; Seoudy K; Rohde H; Lohse AW; Wichmann D; Baehr M; Rothe C; Kluge S
    BMC Infect Dis; 2017 Feb; 17(1):131. PubMed ID: 28178922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.